The Incidence and Risk Factors of Early Periprosthetic Joint Infections


Tekin-Tas Z., ÖZGER H. S., KANATLI U., HIZEL K.

INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, sa.2, ss.93-101, 2024 (ESCI) identifier identifier

Özet

Objective: Periprosthetic joint infections (PJI) represent major complications in arthroplasty, contributing to increased patient morbidity and imposing substantial financial burdens. Meticulous surveillance of PJI occurrences and identification of associated risk factors imperative for accurately gauging the incidence rates and implementing proactive infection control measures. This study aimed to ascertain the early incidence of PJI and elucidate the key risk factors involved in its occurrence. Materials and Methods: This monocentric, prospective descriptive study conducted tween June 2018 and June 2019, including all patients aged 18 years and above who derwent hip and knee arthroplasty. The research documented and evaluated patient mographic characteristics, clinical findings, laboratory results, treatment practices, potential risk factors associated with the surgical process. After the 90 -day postoperative period, patients were categorized into PJI and non-PJI groups, allowing for a comprehensive comparison of identified risk factors. Results: This study identified a cohort of 590 patients, of whom 185 underwent hip throplasties (31.4%) and 405 underwent knee arthroplasties (68.6%). The average age the patients was 65.2 years, with females constituting 80.2% of the population. The overall incidence of early PJI was found to be 2.88% (n=17). Following hip arthroplasties, the PJI cidence was 4.86%, while knee arthroplasties exhibited a lower incidence of 1.9%. Several potential risk factors associated with PJI were identified, including comorbid diseases justed odds ratio [aOR]=3.35, 95% confidence interval [CI]=1.18-9.47), preoperative length of stay (aOR=0.89, 95% CI=0.79-1.01), postoperative erythrocyte suspension replacement (aOR=1.96, 95% CI=0.71-5.44), and a National Nosocomial Infections Surveillance System (NNIS) score of 1 or higher (aOR=3.10, 95% CI=1.10-8.71). These factors were identified potential contributors to the risk of PJI in patients undergoing hip and knee arthroplasties. Conclusion: Compared to other reported outcomes in the literature, this study observed higher incidence of early -stage PJI. The higher incidence may be due to PJI surveillance ciencies such as difficulty in post -discharge surgical site infection (SSI) follow-up, reporting, and bacterial sampling. This discrepancy underscores the importance of actively monitoring patients with risk factors for PJI development, including medical comorbidities and high NNIS score. Implementing prospective active surveillance in such cases is deemed crucial for the timely identification and management of PJI.